Abstract
Despite the clonal origin of most tumors, their tremendous heterogeneity suggests that cancer progression springs from the combined forces of both genetic and epigenetic events, which produce variant clonal populations, together with the selective pressures of the microenvironment, which promote growth and, perhaps, dissemination of variants with a specific set of characteristics. Although the importance of genetic mutations in cancer has long been recognized, the role of epigenetic events has been suggested more recently. This review focuses on the genetic and epigenetic molecular mechanisms involved in cancer onset and progression, and discusses the possibility of new strategies in the development of anticancer treatments.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams PD . (2001). Biochim. Biophys. Acta, 1471, M123–M133.
Aplin AE, Howe A, Alahari SK and Juliano RL . (1998). Pharmacol. Rev., 50, 197–263.
Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J . (1996). Cancer Res., 56, 5475–5483.
Beasley MB, Lantuejoul S, Abbondanzo S, Chu WS, Hasleton PS, Travis WD and Brambilla E . (2003). Hum. Pathol., 34, 136–142.
Bernards R and Weinberg RA . (2002). Nature, 418, 823.
Bird AP and Wolffe AP . (1999). Cell, 99, 451–454.
Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB and Hruban RH . (1998). Am. J. Surg. Pathol., 22, 163–169.
Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM . (1984). Science, 224, 1121–1124.
Cairns J . (1975). Nature, 255, 197–200.
Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R and Westra W . (1995). Nat. Genet., 2, 210–212.
Cameron EE, Bachman KE, Myohanen S, Herman J and Baylin SB . (1999). Nat. Genet., 21, 103–107.
Cinti C and Giordano A . (2000). Emerging Ther. Targets, 6, 765–783.
Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG and Kobayashi DK et al. (1998). J. Immunol., 161, 6845–6852.
De Luca A, Mangiacasale R, Severino A, Malquori L, Baldi A, Palena A, Mileo AM, Lavia P and Paggi MG . (2003). Cancer Res., 63, 1430–1437.
Ding HF and Fisher DE . (2002). Ann. Med., 34, 451–469.
Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Issac JT and Barret JC . (1995). Science, 268, 884–886.
Duensing S, Duensing A, Crum CP and Munger K . (2001). Cancer Res., 61, 2356–2360.
Dyson N . (1998). Genes Dev., 12, 2245–2262.
Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB and Herman JG . (2001). Hum. Mol. Genet., 26, 3001–3007.
Frank SA . (2003). Curr. Biol., 13, R261–R263.
Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A and Van Meir EG . (2000). Oncogene, 19, 3816–3822.
Gan D-D, Macaluso M, Cinti C, Khalili K and Giordano A . (2003). J. Exp. Clin. Cancer Res.. (in press).
Gatenby RA and Maini PK . (2003). Nature, 421, 321.
Giaccia AJ and Kastan M . (1998). Genes Dev., 12, 2973–2983.
Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA . (1995). Cancer Res., 20, 4531–4535.
Habets GGM, Scholtes EHM, Zuydgeest D, van der Kamman RA, Stamj C, Berns A and Collard JG . (1994). Cell, 77, 537–549.
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW and Weinberg RA . (1999). Nature, 400, 464–468.
Hahn WC and Weinberg RA . (2002). N. Engl. J. Med., 347, 1593–1603.
Hajes JJ and Hansen JC . (2001). Curr. Opin. Genet. Dev., 11, 124–129.
Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.
Hartwell LH and Kastan MB . (1994). Science, 266, 1821–1828.
Hashimoto Y, Shindo-Okada N, Tani M, Nagamachi Y, Takeuchi K, Shiroishi T, Toma H and Yokota J . (1998). J. Exp. Med., 187, 289–296.
Haupt Y, Maya R, Kazaz A and Oren M . (1997). Nature, 387, 296–299.
Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K and Yuasa Y . (2000). Int. J. Cancer, 5, 654–658.
Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW and Vogelstein B . (1994). Cancer Res., 24, 6353–6358.
Jones PA and Baylin SB . (2002). Nat. Rev. Genet., 3, 415–428.
Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landesberger N, Strouboulis J and Wolffe AP . (1998). Nat. Genet., 19, 187–191.
Kaelin Jr WG . (1999). BioEssays, 21, 950–958.
Kalebic T . (2003). Ann. Acad. Sci., 293, 278–285.
Kim J, Yu W, Kovalski K and Ossowski L . (1998). Cell, 94, 353–362.
Kinzler KW and Vogelstein B . (1996). Nature, 379, 19–20.
Kinzler KW and Vogelstein B . (1997). Nature, 386, 761–763.
Konopka G and Bonni A . (2003). Curr. Mol. Med., 3, 73–84.
Laird PW and Jaenisch R . (1996). Annu. Rev. Genet., 30, 441–464.
La Sala D, Macaluso M, Trimarchi C, Giordano A and Cinti C . (2003). Oncogene, 22, 3518–3529.
Lavia P, Mileo AM, Giordano A and Paggi MG . (2003). Oncogene, 22, 6508–6516.
Lee JH and Welch DR . (1997). Cancer Res., 57, 2384–2387.
Lengauer C, Kinzler KW and Vogelstein B . (1998). Nature, 396, 643–649.
Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA and Steeg PS . (1991). Cell, 1, 23–35.
Macaluso M, Cinti C, Russo G, Russo A and Giordano A . (2003). Oncogene, 22, 3511–3517.
Macaluso M, Russo G, Cinti C, Bazan V, Gebbia N and Russo A . (2002). J. Cell. Physiol., 192, 125–130.
Mælandsmo GM, Florenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Borresen AL and Fodstad O . (1996). Br. J. Cancer, 73, 909–916.
Meijer L . (1995). Prog. Cell. Cycle Res., 1, 351–363.
Mittnacht S . (1998). Curr. Opin. Genet. Dev., 8, 21–27.
Muegge K, Young H, Ruscetti F and Mikovits J . (2003). Ann. Acad. Sci., 983, 55–70.
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN and Bird A . (1998). Nature, 393, 386–389.
Nephew KP and Huang TH . (2003). Cancer Lett., 190, 125–133.
Newcomb EW, Alonso M, Sung T and Miller DC . (2000). Hum. Pathol., 31, 115–119.
Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL and Croce CM . (1994). Cancer Res., 54, 5269–5272.
Owa T, Yoshino H, Yoshimatsu K and Nagasu T . (2001). Curr. Med. Chem., 8, 1478–1503.
Paggi MG and Giordano A . (2001). Cancer Res., 61, 4651–4654.
Raj K, Ogston P and Beard P . (2001). Nature, 412, 914–917.
Ruas M and Peters G . (1998). Biochim. Biophys. Acta, 1378, F115–F177.
Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G Morello V, Dardanoni G Latteri MA, Colucci G, Tomasino RM and Gebbia N . (2001). Cancer, 92, 294–302.
Russo A, Migliavacca M, Zanna I, Macaluso M, Gebbia N and Bazan V . (2003). Encycl. Hum. Genome. (in press).
Saikawa Y, Kubota T, Otani Y, Kitajima M and Modlin IM . (2001). Jpn. J. Cancer Res., 10, 1102–1109.
Sandal T . (2002). Oncologist, 7, 73–81.
Sarkar S, Julicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF and Reznikoff CA . (2000). Cancer Res., 14, 3862–3872.
Schultz C, Link A and Leost M et al. (1999). J. Med. Chem., 42, 2909–2919.
Senderowicz AM . (2003). Oncogene Rev, 22, 6609–6620.
Sherr CJ . (2000). Cancer Res., 60, 3689–3695.
Sherr CJ and McCormick . (2002). Cancer Cell, 2, 103–112.
Silva J, Silva JM, Dominguez G, Garcia Jm, Cantos B, Rodriguez R, Larrondo FJ, Provencio M, Espana P and Bonilla F . (2003). J. Pathol., 199, 289–297.
Skubitz AP . (2002). Cancer Treat. Res., 107, 305–329.
Slamon DJ, Godolphin W and Jones LA et al. (1989). Science, 244, 707–712.
Steeg PS and Zhou Q . (1998). Breast Cancer Res. Treat., 52, 17–28.
Stewart CL, Soria AM and Hamel PA . (2001). J. Neurooncol., 51, 183–204.
Strahl BD and Allis CD . (2000). Nature, 403, 41–45.
Sutherland JE and Costa M . (2003). Ann. Acad. Sci., 983, 151–160.
Tempia-Caliera AA, Horvath LZ, Zimmermann A, Tihanyi TT, Korc M and Friess H et al. (2002). J. Surg. Oncol., 9, 668–674.
Tetsu O and McCormick F . (1999). Nature, 398, 422–426.
Toh Y, Pencil SD and Nicolson GL . (1994). Biol. Chem., 269, 22958–22963.
Toyota M, Itoh F, Kikuchi T, Satoh A, Obata T, Suzuki H, Ishii S, Endo T, Tokino T and Imai K . (2002). J. Gastroenterol, 37, 97–101.
Tonini T, Rossi F and Claudio PP . (2003). Oncogene Rev. 22, 6549–6556.
Vignali M, Hassan AH, Neely KE and Workam JL . (2000). Mol. Cell. Biol., 20, 1899–1910.
von Willebrand M, Zacksenhaus E, Cheng E, Glazer P and Halaban R . (2003). Cancer Res., 63, 1420–1429.
Wei W, Jobling WA, Chen W, Hahn WC and Sedivy JM . (2003). Mol. Cell. Biol., 23, 2859–2870.
Woodwock DM, Linsenmeyer ME, Doherty JP and Warren WD . (1999). Br. J. Cancer, 79, 251–256.
Yamasaki L. . 2003. Cancer Treat. Res., 115, 209–239.
Yasui W, Oue N, Ono S, Mitani Y, Ito R and Nakayama H . (2003). Ann. Acad. Sci., 983, 220–231.
Yu Q, Geng Y and Sicinski P . (2001). Nature, 411, 1017–1021.
Zhang HS, Postigo AA and Dean DC . (1999). Cell, 97, 53–61.
Zhang Y, Xiong Y and Yarbrough WG . (1998). Cell, 92, 725–734.
Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, Trias M and Wiencke JK . (2000). Carcinogenesis, 21, 2057–2064.
Zheng L and Lee WH . (2000). Exp. Cell Res., 264, 2–18.
Zini N, Trimarchi C, Claudio PP, Stiegler P, Marinelli F, Maltarello MC, La Sala D, DE Falco G, Russo G, Ammirati G, Maraldi MN, Giordano A and Cinti C . (2001). J. Cell. Physiol., 83, 34–44.
Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD . (2001). Cancer Res., 61, 249–255.
Zochbauer-Muller S, Minna JD and Gazdar AF . (2002). Oncologist, 7, 451–456.
Acknowledgements
Research in our laboratories was supported by NIH grants and Sbarro Health Research Organization funds to AG and Associazione Italiana per la Ricerca sul Cancro (AIRC) and Ministero della Salute grants to MGP.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Macaluso, M., Paggi, M. & Giordano, A. Genetic and epigenetic alterations as hallmarks of the intricate road to cancer. Oncogene 22, 6472–6478 (2003). https://doi.org/10.1038/sj.onc.1206955
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206955
Keywords
This article is cited by
-
Bioinformatics analysis of recurrent deletion regions in neuroblastoma
Medical Oncology (2022)
-
GSTs polymorphisms are associated with epigenetic silencing of CDKN2A gene in esophageal squamous cell carcinoma
Environmental Science and Pollution Research (2020)
-
Targeting type Iγ phosphatidylinositol phosphate kinase inhibits breast cancer metastasis
Oncogene (2015)
-
Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse
Frontiers of Medicine (2015)
-
Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia
Prostate Cancer and Prostatic Diseases (2013)